Search

Home > OncLive® On Air > 26: FDA Approval Insights: Brexucabtagene Autoleucel in Relapsed/Refractory MCL
Podcast: OncLive® On Air
Episode:

26: FDA Approval Insights: Brexucabtagene Autoleucel in Relapsed/Refractory MCL
Category: Science & Medicine
Duration: 00:14:53
Publish Date: 2020-08-03 15:04:42
Description: In an interview with OncLive, Dr. Wang discusses the FDA approval of brexucabtagene autoleucel in relapsed/refractory mantle cell lymphoma and ongoing research aimed at optimizing the safety and persistence of the product.
Total Play: 0

Some more Podcasts by Audioboom

70+ Episodes
Faith Moveme ..    
100+ Episodes
Videnskab.dk .. 5     1
20+ Episodes
Vidensselska ..    
10+ Episodes
Odd Jobs    
20+ Episodes
Aaron and Ga ..    
100+ Episodes
Ladies of Li .. 4     3
100+ Episodes
Chamber Podc ..    
10+ Episodes
IT'S A GROWN ..